Scott Hutton - 12 Aug 2025 Form 4 Insider Report for BIODESIX INC (BDSX)

Role: President & CEO, Director
Signature: /s/ Robin H. Cowie as Attorney-in-Fact for Scott Hutton
Issuer symbol: BDSX
Transactions as of: 12 Aug 2025
Net transactions value: -$1,570
Form type: 4
Filing time: 14 Aug 2025, 17:25:03 UTC
Previous filing: 13 May 2025
Next filing: 13 Nov 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Hutton Scott	President & CEO, Director	919 WEST DILLON RD, LOUISVILLE	/s/ Robin H. Cowie as Attorney-in-Fact for Scott Hutton	14 Aug 2025	0001697361

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BDSX	Common Stock	Options Exercise		+12,212	+1.7%		732,596	12 Aug 2025	Direct	F1
transaction	BDSX	Common Stock	Sale	$1,570	-3,772	-0.51%	$0.4163	728,824	13 Aug 2025	Direct	F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BDSX	Restricted Stock Units	Options Exercise	$0	-12,212	-33%	$0.000000	24,424	12 Aug 2025	Common Stock	12,212		Direct	F1, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F2	These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs.
F3	The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $0.4076 to $0.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4	These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.